ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $48,475,000 | +40.8% | 1,447,002 | +11.9% | 0.01% | +28.6% |
| Q3 2016 | $34,423,000 | +29.9% | 1,293,604 | +7.6% | 0.01% | +16.7% |
| Q2 2016 | $26,503,000 | -23.8% | 1,201,932 | +1.5% | 0.01% | -25.0% |
| Q1 2016 | $34,774,000 | -8.4% | 1,184,007 | +2.9% | 0.01% | -11.1% |
| Q4 2015 | $37,981,000 | -8.9% | 1,150,230 | -0.3% | 0.01% | -18.2% |
| Q3 2015 | $41,711,000 | +40.4% | 1,154,139 | +74.8% | 0.01% | +57.1% |
| Q2 2015 | $29,700,000 | +84.2% | 660,148 | +25.4% | 0.01% | +75.0% |
| Q1 2015 | $16,125,000 | -37.4% | 526,625 | +4.0% | 0.00% | -33.3% |
| Q4 2014 | $25,758,000 | +161.2% | 506,542 | +103.2% | 0.01% | +100.0% |
| Q3 2014 | $9,863,000 | -10.1% | 249,249 | -2.1% | 0.00% | 0.0% |
| Q2 2014 | $10,970,000 | +167.3% | 254,706 | +148.2% | 0.00% | +200.0% |
| Q1 2014 | $4,104,000 | +50.8% | 102,624 | +2.9% | 0.00% | 0.0% |
| Q4 2013 | $2,722,000 | +13.9% | 99,780 | -4.3% | 0.00% | 0.0% |
| Q3 2013 | $2,389,000 | +46.8% | 104,228 | +13.5% | 0.00% | 0.0% |
| Q2 2013 | $1,627,000 | – | 91,844 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |